Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03018405
Title A Dose Escalation Phase I Study to Assess the Safety and Clinical Activity of Multiple Cancer Indications (THINK)
Acronym THINK
Recruitment Unknown status
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Celyad Oncology SA
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | BEL


No variant requirements are available.